LLY vs PFE
ELI Lilly & Co. and Pfizer Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | LLY | PFE |
|---|---|---|
| Revenue | $65.2B | $62.6B |
| Net income | $20.6B | $7.8B |
| Gross margin | 83.0% | 74.3% |
| Net margin | 31.7% | 12.5% |
| Return on equity | 101.2% | 8.9% |
| Diluted EPS | $22.95 | $1.36 |
| Dividend / share | $6.23 | $1.72 |
| Payout ratio | 26.1% | · |
| Free cash flow | · | $9.1B |
| Equity | $26.5B | $86.5B |
| Net debt / equity | 1.33× | 0.73× |
| Current ratio | 1.58× | 1.16× |
| Revenue CAGR 5y | 21.6% | 8.5% |
| Profit CAGR 5y | 27.2% | −3.2% |
LLY and PFE book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (31.7% against 12.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | LLY | PFE |
|---|---|---|
| FY2025 | $65.2B | $62.6B |
| FY2024 | $45.0B | $63.6B |
| FY2023 | $34.1B | $59.6B |
| FY2022 | $28.5B | $101.2B |
| FY2021 | $28.3B | $81.3B |
| FY2020 | $24.5B | $41.7B |
| FY2019 | $22.3B | $40.9B |
| FY2018 | $21.5B | $40.8B |
| FY2017 | $20.0B | $52.5B |
| FY2016 | $21.2B | $52.8B |
Bottom line
| Fiscal year | LLY | PFE |
|---|---|---|
| FY2025 | $20.6B | $7.8B |
| FY2024 | $10.6B | $8.0B |
| FY2023 | $5.2B | $2.1B |
| FY2022 | $6.2B | $31.4B |
| FY2021 | $5.6B | $22.0B |
| FY2020 | $6.2B | $9.2B |
| FY2019 | $8.3B | $16.0B |
| FY2018 | $3.2B | $11.2B |
| FY2017 | $-204.1M | $21.3B |
| FY2016 | $2.7B | $7.2B |
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$2,600,000,000 | LLY |
| FY2024 | −$18,584,000,000 | PFE |
| FY2023 | −$25,429,000,000 | PFE |
| FY2022 | −$72,633,600,000 | PFE |
| FY2021 | −$52,969,600,000 | PFE |
| FY2020 | −$17,111,200,000 | PFE |
| FY2019 | −$18,585,500,000 | PFE |
| FY2018 | −$19,331,700,000 | PFE |
| FY2017 | −$32,572,200,000 | PFE |
| FY2016 | −$31,601,900,000 | PFE |
| FY2015 | −$28,892,300,000 | PFE |
| FY2014 | −$29,989,400,000 | PFE |
| FY2013 | −$28,470,900,000 | PFE |
| FY2012 | −$32,053,600,000 | PFE |
| FY2011 | −$36,748,500,000 | PFE |
| FY2010 | −$42,089,000,000 | PFE |
| FY2009 | −$27,433,000,000 | PFE |
| FY2008 | −$27,924,100,000 | PFE |
| FY2007 | −$29,784,500,000 | PFE |
The higher-revenue side has changed between LLY and PFE over this period. The gap has narrowed since the earliest year compared.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +19.2 pp | LLY |
| FY2024 | +10.8 pp | LLY |
| FY2023 | +11.7 pp | LLY |
| FY2022 | −9.2 pp | PFE |
| FY2021 | −7.4 pp | PFE |
| FY2020 | +3.2 pp | LLY |
| FY2019 | −2.0 pp | PFE |
| FY2018 | −12.4 pp | PFE |
| FY2017 | −41.7 pp | PFE |
| FY2016 | −0.8 pp | PFE |
| FY2015 | −2.2 pp | PFE |
| FY2014 | −6.3 pp | PFE |
| FY2013 | −22.5 pp | PFE |
| FY2012 | −8.6 pp | PFE |
| FY2011 | +1.4 pp | LLY |
| FY2010 | +9.3 pp | LLY |
| FY2009 | +2.3 pp | LLY |
| FY2008 | −27.0 pp | PFE |
| FY2007 | −1.1 pp | PFE |
The higher net margin has changed hands between LLY and PFE over this period.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
PFE's net margin has been more volatile than LLY's over the 19 comparable fiscal years — 10.5 percentage points of standard deviation against 10.1.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between LLY and PFE over these 19 fiscal years — LLY led in 7 and PFE in 12.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LLY's return on equity has been more volatile than PFE's over the 18 comparable fiscal years — 44.6 percentage points of standard deviation against 9.4.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between LLY and PFE over these 18 fiscal years — LLY led in 16 and PFE in 2.
18 of 19 comparable fiscal years — a year missing data on either side is not counted.